The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
potentially the most important study of this is not yet out yet which is this IT p4n are in mice correct that should be the most robust analysis of NRO should it not in mice it is so they used mixed strains they use a variety of labs across the country and so that's it's considered a standard but it's not definitive because there are plenty of ways to dose plenty of ways to deliver it plenty of molecules in our kit
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.